Mitsubishi UFJ Trust & Banking Corp increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 98.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 350,848 shares of the company’s stock after acquiring an additional 174,137 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned about 0.22% of Henry Schein worth $28,766,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Intrust Bank NA boosted its position in Henry Schein by 1.1% in the 2nd quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock valued at $223,000 after buying an additional 13 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Henry Schein by 0.3% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,894 shares of the company’s stock valued at $1,079,000 after buying an additional 19 shares during the last quarter. YorkBridge Wealth Partners LLC boosted its position in Henry Schein by 5.2% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after buying an additional 28 shares during the last quarter. Sawtooth Solutions LLC boosted its position in Henry Schein by 2.4% in the 2nd quarter. Sawtooth Solutions LLC now owns 1,347 shares of the company’s stock valued at $247,000 after buying an additional 32 shares during the last quarter. Finally, Wedbush Securities Inc. boosted its position in Henry Schein by 3.8% in the 2nd quarter. Wedbush Securities Inc. now owns 1,600 shares of the company’s stock valued at $293,000 after buying an additional 58 shares during the last quarter. Institutional investors and hedge funds own 91.75% of the company’s stock.
Henry Schein, Inc. (HSIC) opened at $71.10 on Wednesday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.86. The firm has a market capitalization of $11,160.00, a price-to-earnings ratio of 19.82, a PEG ratio of 1.99 and a beta of 0.99. Henry Schein, Inc. has a 12 month low of $65.28 and a 12 month high of $93.50.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). The company had revenue of $3.16 billion during the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period last year, the company earned $0.84 EPS. sell-side analysts forecast that Henry Schein, Inc. will post 3.6 earnings per share for the current year.
Henry Schein declared that its board has authorized a share buyback plan on Monday, September 18th that authorizes the company to repurchase $400.00 million in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 6.3% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.
HSIC has been the topic of a number of recent research reports. Credit Suisse Group reiterated a “hold” rating and issued a $87.50 price objective on shares of Henry Schein in a research report on Tuesday, August 29th. Piper Jaffray Companies upgraded Henry Schein from a “neutral” rating to an “overweight” rating in a research report on Friday, September 15th. Craig Hallum upgraded Henry Schein from a “hold” rating to a “buy” rating in a research report on Tuesday, November 7th. Zacks Investment Research lowered Henry Schein from a “hold” rating to a “sell” rating in a research report on Monday, November 13th. Finally, Morgan Stanley initiated coverage on Henry Schein in a research report on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 price objective on the stock. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and seven have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $88.36.
In other news, Director Barry J. Alperin sold 5,796 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $70.76, for a total value of $410,124.96. Following the transaction, the director now owns 48,172 shares of the company’s stock, valued at approximately $3,408,650.72. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.19% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Henry Schein, Inc. (HSIC) Shares Bought by Mitsubishi UFJ Trust & Banking Corp” was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://ledgergazette.com/2017/12/06/henry-schein-inc-hsic-shares-bought-by-mitsubishi-ufj-trust-banking-corp.html.
Henry Schein Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.